Mark Rosenfeld

Mark Rosenfeld

Company: Ananda Scientific

Job title: Chief Executive Officer & Chief Science Officer


CBD as a Pharmaceutical: Requirements and Phase 1 Clinical Trial Results 5:00 pm

Increasing the oral bioavailability of CBD, in a manner acceptable to regulatory authorities in the United States and elsewhere, is essential to making it a reliable medicine A Phase 1 PK shows confirms that ANANDA Scientific’s uniquely enhanced CBD, or Liquid StructureTM CBD, rapidly and prodigiously enters the body, with Tmax at 1 hour instead…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.